CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Simplifying Adenoviral Purification For Scalable Manufacturing

  As vector design advances, downstream purification limits adenoviral manufacturing. A membrane-integrated hybrid train reduces product loss and process complexity at scale.

• Crude Peptide Purification Optimization For Scalable Manufacturing

  Transitioning lentiviral vectors to final drug product raises quality demands. A simplified membrane-based capture step minimizes downstream losses that can constrain systemic dosing.

• The Value Of Peptones For Enhancing Biopharmaceutical Productivity

  Peptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.

• Efficient Clone Screening With Increased Process Control And Integrated Cell Health And Titer Measurements With The Cydem VT Automated Clone Screening System

  Automated screening of antibody-producing clones provides real-time cell health and titer data, helping developers identify top-performing candidates earlier and with confidence.

• End-To-End Clinical, Biometrics, And Regulatory Support In Neurology

  Discover how an integrated NDA strategy aligned data, vendors, and regulatory execution to achieve an on-time submission and approval without major FDA queries.

• How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing

  Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.

• Product Recovery Study For Fill Finish Applications

  Surge bags are essential to fill finish efficiency, but poor drainage can cause costly product loss. Learn how drainage testing helps identify high-performance bags that maximize recovery and reduce waste.

• Developing Consistent And Reproducible 3D Spheroid Models

  Improve 3D spheroid consistency by optimizing cell selection, seeding density, and plate geometry. See how practical workflows and comparative data help reduce variability and establish reliability.

• Pharmacovigilance Is Not A Checkbox: Rethinking Safety Monitoring From Day One

  Cell and gene therapies demand a pharmacovigilance approach built from the ground up, not adapted from frameworks designed for conventional drug products.

• Inside The Payer Perspective On Cell And Gene Therapy Coverage

  Find out what 19 US payer organizations revealed about CGT coverage decisions, pre-approval engagement timelines, and the clinical evidence they need most to approve high-cost therapies.